Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000359501 | SCV000344417 | uncertain significance | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001141449 | SCV001301794 | likely benign | Pigmentary pallidal degeneration | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV001141449 | SCV002426147 | likely benign | Pigmentary pallidal degeneration | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Department of Neurology, |
RCV001141449 | SCV002553236 | uncertain significance | Pigmentary pallidal degeneration | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003957511 | SCV004774887 | likely benign | PANK2-related disorder | 2020-03-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |